Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group.
Massi D, Szumera-Ciećkiewicz A, Alos L, Simi S, Ugolini F, Palmieri G, Stanganelli I, Cook MG, Mandalà M. Massi D, et al. Among authors: alos l. Eur J Cancer. 2023 Aug;189:112921. doi: 10.1016/j.ejca.2023.05.009. Epub 2023 May 16. Eur J Cancer. 2023. PMID: 37280145 Free article.
The difficulty with measuring the largest melanoma tumour diameter in sentinel lymph nodes.
Laeijendecker AE, El Sharouni MA, Stathonikos N, Spoto CPE, van de Wiel BA, Eijken EJE, Mulder M, Mooyaart AL, Szumera-Cieckiewicz A, Mihic-Probst D, Massi D, Cook M, Koljenovic S, Alos L, van Diest PJ, van Akkooi ACJ, Blokx W. Laeijendecker AE, et al. Among authors: alos l. J Clin Pathol. 2024 May 17;77(6):372-377. doi: 10.1136/jcp-2023-209354. J Clin Pathol. 2024. PMID: 38378246
Criteria for melanocytic lesions in LC-OCT.
Perez-Anker J, Soglia S, Lenoir C, Albero R, Alos L, García A, Alejo B, Cinotti E, Orte Cano C, Habougit C, Dorado Cortes C, Pellegrino L, Tognetti L, Castillo P, Rubegni P, Suppa M, Perrot JL, Del Marmol V, Puig S, Malvehy J. Perez-Anker J, et al. Among authors: alos l. J Eur Acad Dermatol Venereol. 2024 Oct;38(10):2005-2016. doi: 10.1111/jdv.20079. Epub 2024 May 10. J Eur Acad Dermatol Venereol. 2024. PMID: 38727525
Margin control of lentigo maligna with SOX10-frozen section immunostaining: A case series.
Albero-González R, Marti-Marti I, Alós L, Castillo P, Castrejón N, Alegre M, Morgado-Carrasco D, Pérez-Ánker J, Pina N, Godoy C, Martínez A, García A, Toll A. Albero-González R, et al. Among authors: alos l. Australas J Dermatol. 2023 Nov;64(4):544-546. doi: 10.1111/ajd.14132. Epub 2023 Jul 18. Australas J Dermatol. 2023. PMID: 37461823 No abstract available.
High-risk mucosal human papillomavirus-associated squamous cell carcinoma of the fingers presents distinctive clinicopathological characteristics and outcomes: a bicentric retrospective study.
Marti-Marti I, Bosch-Amate X, Morgado-Carrasco D, Albero-González R, Santos-Briz A, Puebla-Tornero L, Revelles-Peñas L, Cañueto J, Alòs L, Toll A. Marti-Marti I, et al. Among authors: alos l. Clin Exp Dermatol. 2023 Mar 1;48(3):211-217. doi: 10.1093/ced/llac086. Clin Exp Dermatol. 2023. PMID: 36763739
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma.
Ewen T, Husain A, Stefanos N, Barrett P, Jones C, Ness T, Long A, Horswell S, Bosomworth H, Lowenstein J, Richardson G, Swan D, McConnell A, Rose A, Andrew T, Reynolds N, Malvehy J, Carrera C, Alos L, Mailer S, Helm T, Ding L, Bogner P, Podlipnik S, Puig S, McArthur GA, Paragh G, Labus M, Sloan P, Armstrong JL, Lovat PE. Ewen T, et al. Among authors: alos l. Br J Dermatol. 2024 Mar 15;190(4):549-558. doi: 10.1093/bjd/ljad459. Br J Dermatol. 2024. PMID: 38006317
Feasibility and Impact of Embedding an Extended DNA and RNA Tissue-Based Sequencing Panel for the Routine Care of Patients with Advanced Melanoma in Spain.
Castrejon N, Martin R, Carrasco A, Castillo P, Garcia A, Albero-González R, García M, Marginet M, Palau N, Hernández M, Montironi C, Clot G, Arance A, Alos L, Teixido C. Castrejon N, et al. Among authors: alos l. Int J Mol Sci. 2024 Jun 25;25(13):6942. doi: 10.3390/ijms25136942. Int J Mol Sci. 2024. PMID: 39000050 Free PMC article.
[Translated article] S100-protein-negative Mouth Lesion.
Saez de Gordoa K, Alos L, Albero-González R. Saez de Gordoa K, et al. Among authors: alos l. Actas Dermosifiliogr. 2024 Jun;115(6):T597-T598. doi: 10.1016/j.ad.2024.04.003. Epub 2024 Apr 21. Actas Dermosifiliogr. 2024. PMID: 38653366 Free article. English, Spanish. No abstract available.
Melanoma on congenital melanocytic nevi.
Alos L, Carrasco A, Teixidó C, Szumera-Ciećkiewicz A, Vicente A, Massi D, Carrera C. Alos L, et al. Pathol Res Pract. 2024 Apr;256:155262. doi: 10.1016/j.prp.2024.155262. Epub 2024 Mar 11. Pathol Res Pract. 2024. PMID: 38518732 Review.
Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
Moysset I, Castrejon N, Garcia-Herrera A, Castillo P, Marginet M, Teixido C, Podlipnik S, Albero-Gonzalez R, Montironi C, Navarro J, Rovira C, Puig S, Carrera C, Alos L. Moysset I, et al. Among authors: alos l. Histopathology. 2024 Jun;84(7):1154-1166. doi: 10.1111/his.15160. Epub 2024 Feb 26. Histopathology. 2024. PMID: 38409889
178 results